Programme(s) to which this project applies:
|☑ MPhil/PhD||☒ MRes[Med]||☒ URIS|
Our knowledge of the gut microbiome has expanded exponentially over the last decade. The availability of next-generation and third-generation sequencing technology has allowed an in-depth understanding into the gut microbiome’s metagenomics. Microbiome-based pharmaceutical therapies to treat a variety of disease entities are emerging. This project aims at utilising established animal models in the investigation of gut microbiome changes that are causally related to different chronic liver diseases, and which can emerge as potential microbiome-based diagnostic and therapeutic targets. The project utilises the germ-free gnotobiotic facilities of our institution, as well as the available high-throughput next-generation and third-generation metagenomic sequencing facilities. The option of associated genomic, proteomic and metabolomic studies are available. Support for bioinformatics analysis is also provided.
Professor WWK Seto, Department of Medicine
Prof Wai-Kay Seto graduated from the University of Hong Kong and received his Fellowship in Gastroenterology and Hepatology from the Hong Kong College of Physicians and his Doctor of Medicine from the University of Hong Kong in 2012. He is currently a Clinical Professor in the Department of Medicine and Principal Investigator of the State Key Laboratory of Liver Disease, the University of Hong Kong, Hong Kong. He is also Assistant Hospital Chief Executive (Research) and Medical Director, Clinical Trials Center of the University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Prof Seto is currently ranked by Clarivate Analytics in the top 1% worldwide by research. He has published more than 200 international journal articles and book chapters, including leading-authored articles in the Lancet, Journal of Clinical Oncology, Nature Reviews Gastroenterology & Hepatology, Journal of Hepatology, Gut, Hepatology and American Journal of Gastroenterology, majority related to research on chronic liver diseases. He has secured a total of over 25 million HKD in external competitive grant funding, has over 90 local, regional and international invited lectureships. He is a principal investigator of over 10 phase I-III international industry-sponsored clinical trials.
Prof Seto has been awarded the American Gastroenterological Association Fellowship (2021); Sir David Todd Lectureship, Hong Kong College of Physicians (2019); the Asia-Pacific Digestive Week Emerging Leader from the APDW Federation (2018); Faculty Knowledge Exchange Award (2018), The University of Hong Kong; Guangdong Province Outstanding Young Medical Talent Award (2017); Outstanding Young Research Award (2016-2017) from The University of Hong Kong; and the Distinguished Young Fellow (2013) from the Hong Kong Academy of Medicine.
For more information or to express interest for this project, please email the supervisor or the specified contact point in the project description. Interested candidates are advised to enclose with your email:
Information on the research programme, funding support and admission documentations could be referenced online at the Research Postgraduate Admissions website.
General admission enquiries should be directed to firstname.lastname@example.org.